Trials / Completed
CompletedNCT03480243
Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil
An Open-label, Fixed-sequence Study in Healthy Study Participants to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- UCB Biopharma S.P.R.L. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate and compare the Pharmacokinetics (PK) of concomitant administration of Padsevonil (PSL) in the presence and absence of erythromycin in healthy study participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Padsevonil (UCB0942) | * Pharmaceutical Form: film-coated tablet * Route of Administration: Oral use |
| DRUG | Erythromycin | * Pharmaceutical Form: film-coated tablet * Route of Administration: Oral use |
Timeline
- Start date
- 2018-03-27
- Primary completion
- 2018-08-02
- Completion
- 2018-08-02
- First posted
- 2018-03-29
- Last updated
- 2021-07-12
- Results posted
- 2021-07-12
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03480243. Inclusion in this directory is not an endorsement.